Ryan Zimmerman
Stock Analyst at BTIG
(3.58)
# 849
Out of 5,182 analysts
251
Total ratings
46.61%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Reiterates: Buy | $574 | $467.00 | +22.91% | 25 | Apr 22, 2026 | |
| GEHC GE HealthCare Technologies | Reiterates: Buy | $85 | $69.63 | +22.07% | 8 | Apr 21, 2026 | |
| SYK Stryker | Reiterates: Buy | $397 | $323.69 | +22.65% | 20 | Apr 14, 2026 | |
| XTNT Xtant Medical Holdings | Maintains: Buy | $1.5 → $1 | $0.53 | +87.06% | 4 | Mar 31, 2026 | |
| HUMA Humacyte | Maintains: Buy | $6 → $3 | $0.77 | +288.45% | 8 | Mar 27, 2026 | |
| ORGO Organogenesis Holdings | Reiterates: Buy | $8 | $2.39 | +234.73% | 12 | Mar 26, 2026 | |
| MDAI Spectral AI | Reiterates: Buy | $3 | $1.93 | +55.84% | 4 | Mar 25, 2026 | |
| ALC Alcon | Reiterates: Buy | $92 | $75.29 | +22.20% | 15 | Mar 23, 2026 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | n/a | $84.32 | - | 12 | Mar 23, 2026 | |
| LNSR LENSAR | Upgrades: Buy | $10 | $5.37 | +86.15% | 2 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $24 | $13.37 | +79.57% | 2 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $24 | $15.55 | +54.34% | 11 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $68.00 | +47.06% | 3 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $43 | $23.72 | +81.28% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $131 | $119.92 | +9.24% | 17 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $23.43 | +62.19% | 6 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $349 | $326.75 | +6.81% | 21 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $9.65 | +148.83% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.27 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.93 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $125.75 | +55.07% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $35.60 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $23.14 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $93.76 | +57.85% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.07 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $91.88 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $10.64 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $25.92 | +104.48% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.11 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $178.50 | +12.04% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $185.65 | +88.53% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $82.31 | +55.51% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $16.62 | +152.78% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $6.06 | +766.34% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $42.94 | - | 3 | Apr 2, 2020 |
Intuitive Surgical
Apr 22, 2026
Reiterates: Buy
Price Target: $574
Current: $467.00
Upside: +22.91%
GE HealthCare Technologies
Apr 21, 2026
Reiterates: Buy
Price Target: $85
Current: $69.63
Upside: +22.07%
Stryker
Apr 14, 2026
Reiterates: Buy
Price Target: $397
Current: $323.69
Upside: +22.65%
Xtant Medical Holdings
Mar 31, 2026
Maintains: Buy
Price Target: $1.5 → $1
Current: $0.53
Upside: +87.06%
Humacyte
Mar 27, 2026
Maintains: Buy
Price Target: $6 → $3
Current: $0.77
Upside: +288.45%
Organogenesis Holdings
Mar 26, 2026
Reiterates: Buy
Price Target: $8
Current: $2.39
Upside: +234.73%
Spectral AI
Mar 25, 2026
Reiterates: Buy
Price Target: $3
Current: $1.93
Upside: +55.84%
Alcon
Mar 23, 2026
Reiterates: Buy
Price Target: $92
Current: $75.29
Upside: +22.20%
Zimmer Biomet Holdings
Mar 23, 2026
Downgrades: Neutral
Price Target: n/a
Current: $84.32
Upside: -
LENSAR
Mar 18, 2026
Upgrades: Buy
Price Target: $10
Current: $5.37
Upside: +86.15%
Mar 11, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $13.37
Upside: +79.57%
Feb 27, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $15.55
Upside: +54.34%
Feb 27, 2026
Reiterates: Buy
Price Target: $100
Current: $68.00
Upside: +47.06%
Feb 26, 2026
Maintains: Buy
Price Target: $41 → $43
Current: $23.72
Upside: +81.28%
Feb 18, 2026
Reiterates: Buy
Price Target: $131
Current: $119.92
Upside: +9.24%
Feb 18, 2026
Maintains: Buy
Price Target: $36 → $38
Current: $23.43
Upside: +62.19%
Jan 16, 2026
Downgrades: Neutral
Price Target: $349
Current: $326.75
Upside: +6.81%
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $9.65
Upside: +148.83%
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $4.27
Upside: -
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.93
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $125.75
Upside: +55.07%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $35.60
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $23.14
Upside: -
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $93.76
Upside: +57.85%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.07
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $91.88
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $10.64
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $25.92
Upside: +104.48%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $12.11
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $178.50
Upside: +12.04%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $185.65
Upside: +88.53%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $82.31
Upside: +55.51%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $16.62
Upside: +152.78%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $6.06
Upside: +766.34%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $42.94
Upside: -